Literature DB >> 24011396

Biological characterization of F-18-labeled rhodamine B, a potential positron emission tomography perfusion tracer.

Mark D Bartholomä1, Huamei He, Christina A Pacak, Patricia Dunning, Frederic H Fahey, Francis X McGowan, Douglas B Cowan, S Ted Treves, Alan B Packard.   

Abstract

INTRODUCTION: Myocardial infarction is the leading cause of death in western countries, and positron emission tomography (PET) plays an increasing role in the diagnosis and treatment planning for this disease. However, the absence of an (18)F-labeled PET myocardial perfusion tracer hampers the widespread use of PET in myocardial perfusion imaging (MPI). We recently reported a potential MPI agent based on (18)F-labeled rhodamine B. The goal of this study was to more completely define the biological properties of (18)F-labeled rhodamine B with respect to uptake and localization in an animal model of myocardial infarction and to evaluate the uptake (18)F-labeled rhodamine B by cardiomyocytes.
METHODS: A total of 12 female Sprague Dawley rats with a permanent ligation of the left anterior descending artery (LAD) were studied with small-animal PET. The animals were injected with 100-150 μCi of (18)F-labeled rhodamine B diethylene glycol ester ([(18)F]RhoBDEGF) and imaged two days before ligation. The animals were imaged again two to ten days post-ligation. After the post-surgery scans, the animals were euthanized and the hearts were sectioned into 1mm slices and myocardial infarct size was determined by phosphorimaging and 2,3,5-triphenyltetrazolium chloride staining (TTC). In addition, the uptake of [(18)F]RhoBDEGF in isolated rat neonatal cardiomyocytes was determined by fluorescence microscopy.
RESULTS: Small-animal PET showed intense and uniform uptake of [(18)F]RhoBDEGF throughout the myocardium in healthy rats. After LAD ligation, well defined perfusion defects were observed in the PET images. The defect size was highly correlated with the infarct size as determined ex vivo by phosphorimaging and TTC staining. In vitro, [(18)F]RhoBDEGF was rapidly internalized into rat cardiomyocytes with ~40 % of the initial activity internalized within the 60 min incubation time. Fluorescence microscopy clearly demonstrated localization of [(18)F]RhoBDEGF in the mitochondria of rat cardiomyocytes.
CONCLUSION: Fluorine-18-labeled rhodamine B diethylene glycol ester ([(18)F]RhoBDEGF) provides excellent image quality and clear delineation of myocardial infarcts in a rat infarct model. In vitro studies demonstrate localization of the tracer in the mitochondria of cardiac myocytes. In combination, these results support the continued evaluation of this tracer for the PET assessment of myocardial perfusion.
© 2013.

Entities:  

Keywords:  Fluorescence; Imaging; Infarct; PET; Perfusion; Rhodamine

Mesh:

Substances:

Year:  2013        PMID: 24011396      PMCID: PMC3820364          DOI: 10.1016/j.nucmedbio.2013.07.006

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  23 in total

1.  A welcomed new myocardial perfusion imaging agent for positron emission tomography.

Authors:  George A Beller; Denny D Watson
Journal:  Circulation       Date:  2009-05-05       Impact factor: 29.690

2.  Photophysical, photochemical, and tumor-selectivity properties of bromine derivatives of rhodamine-123.

Authors:  Silvia H D Lacerda; Bindu Abraham; Thomas C Stringfellow; Guilherme L Indig
Journal:  Photochem Photobiol       Date:  2005 Nov-Dec       Impact factor: 3.421

3.  To use MIBI or not to use MIBI? That is the question when assessing tumour cells.

Authors:  Jean-Luc Moretti; Nathalie Hauet; Meltem Caglar; Olivier Rebillard; Zeynep Burak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

4.  Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose.

Authors:  J Y Choi; S E Kim; H J Shin; B T Kim; J H Kim
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

5.  64Cu-labeled lissamine rhodamine B: a promising PET radiotracer targeting tumor mitochondria.

Authors:  Yang Zhou; Young-Seung Kim; Xin Yan; Orit Jacobson; Xiaoyuan Chen; Shuang Liu
Journal:  Mol Pharm       Date:  2011-05-24       Impact factor: 4.939

6.  Diagnostic accuracy of myocardial perfusion imaging with single photon emission computed tomography and positron emission tomography: a comparison with coronary angiography.

Authors:  Lars Husmann; Mischa Wiegand; Ines Valenta; Oliver Gaemperli; Tiziano Schepis; Patrick T Siegrist; Mehdi Namdar; Christophe A Wyss; Hatem Alkadhi; Philipp A Kaufmann
Journal:  Int J Cardiovasc Imaging       Date:  2007-12-25       Impact factor: 2.357

7.  Effect of the prosthetic group on the pharmacologic properties of 18F-labeled rhodamine B, a potential myocardial perfusion agent for positron emission tomography (PET).

Authors:  Mark D Bartholomä; Vijay Gottumukkala; Shaohui Zhang; Amanda Baker; Patricia Dunning; Frederic H Fahey; S Ted Treves; Alan B Packard
Journal:  J Med Chem       Date:  2012-12-14       Impact factor: 7.446

8.  Mitochondrial localization and characterization of 99Tc-SESTAMIBI in heart cells by electron probe X-ray microanalysis and 99Tc-NMR spectroscopy.

Authors:  D P Piwnica-Worms; J F Kronauge; A LeFurgey; M Backus; D Hockett; P Ingram; M Lieberman; B L Holman; A G Jones; A Davison
Journal:  Magn Reson Imaging       Date:  1994       Impact factor: 2.546

9.  Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography.

Authors:  Daniel S Berman; Jamshid Maddahi; B K Tamarappoo; Johannes Czernin; Raymond Taillefer; James E Udelson; C Michael Gibson; Marybeth Devine; Joel Lazewatsky; Gajanan Bhat; Dana Washburn
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094

10.  Evaluation of a novel (18)F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats.

Authors:  Hossam M Sherif; Antti Saraste; Eliane Weidl; Axel W Weber; Takahiro Higuchi; Sybille Reder; Thorsten Poethko; Gjermund Henriksen; David Casebier; Simon Robinson; Hans-Jürgen Wester; Stephan G Nekolla; Markus Schwaiger
Journal:  Circ Cardiovasc Imaging       Date:  2009-01-26       Impact factor: 7.792

View more
  4 in total

1.  New chemical and radiochemical routes to [18F]Rho6G-DEG-F, a delocalized lipophilic cation for myocardial perfusion imaging with PET.

Authors:  J A H Inkster; S Zhang; V Akurathi; A Belanger; S Dubey; T Treves; A B Packard
Journal:  Medchemcomm       Date:  2017-08-25       Impact factor: 3.597

2.  Development of new copper-64 labeled rhodamine: a potential PET myocardial perfusion imaging agent.

Authors:  Norah AlHokbany; Ibrahim AlJammaz; Basem AlOtaibi; Yousif AlMalki; Bander AlJammaz; Subhani M Okarvi
Journal:  EJNMMI Radiopharm Chem       Date:  2022-07-23

3.  Intracoronary Delivery of Mitochondria to the Ischemic Heart for Cardioprotection.

Authors:  Douglas B Cowan; Rouan Yao; Vamsidhar Akurathi; Erin R Snay; Jerusha K Thedsanamoorthy; David Zurakowski; Maria Ericsson; Ingeborg Friehs; Yaotang Wu; Sidney Levitsky; Pedro J Del Nido; Alan B Packard; James D McCully
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

4.  Smart, Tunable CQDs with Antioxidant Properties for Biomedical Applications-Ecofriendly Synthesis and Characterization.

Authors:  Łukasz Janus; Julia Radwan-Pragłowska; Marek Piątkowski; Dariusz Bogdał
Journal:  Molecules       Date:  2020-02-08       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.